Your browser doesn't support javascript.
loading
Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction.
Palmer, Kirsten R; Mockler, Joanne C; Davies-Tuck, Miranda L; Miller, Suzanne L; Goergen, Stacy K; Fahey, Michael C; Anderson, Peter J; Groom, Katie M; Wallace, Euan M.
Affiliation
  • Palmer KR; Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
  • Mockler JC; Department of Obstetrics and Gynaecology, Monash Health, Clayton, Victoria, Australia.
  • Davies-Tuck ML; Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
  • Miller SL; Department of Obstetrics and Gynaecology, Monash Health, Clayton, Victoria, Australia.
  • Goergen SK; The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Fahey MC; Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
  • Anderson PJ; The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Groom KM; Department of Imaging, Monash University, Clayton, Victoria, Australia.
  • Wallace EM; Department of Radiology, Monash Health, Clayton, Victoria, Australia.
BMJ Open ; 9(6): e028243, 2019 06 22.
Article in En | MEDLINE | ID: mdl-31230020

Full text: 1 Database: MEDLINE Main subject: Fetal Growth Retardation / Neuroprotection / Melatonin / Antioxidants Type of study: Clinical_trials / Guideline / Prognostic_studies Language: En Journal: BMJ Open Year: 2019 Type: Article Affiliation country: Australia

Full text: 1 Database: MEDLINE Main subject: Fetal Growth Retardation / Neuroprotection / Melatonin / Antioxidants Type of study: Clinical_trials / Guideline / Prognostic_studies Language: En Journal: BMJ Open Year: 2019 Type: Article Affiliation country: Australia